The U.S. Government has invested in biodefense technologies applied to individuals: point of care diagnostics, new antibody medicines, and most recently rapid vaccine development. However, personal protective equipment (PPE) and methods to decontaminate environments have not had technological innovation in decades.
XCMR is proud to have been awarded multiple USG contracts, to address the challenges and opportunities to protect individuals in interactions (not just in isolation) and to disinfect air spaces and surfaces in real-time.
Public/Private partnerships continue to play a significant role in the XCMR mission and we are grateful for our deep relationships with our commercial partners. Reach out below to join us in our mission.
